Review continued need/effectiveness after 3 to 6 months
CAUTION: Anticholinergic ADRs (oxybutynin may decrease MMSE score in people with dementia)
Review continued need/effectiveness after 3 to 6 months
CAUTION: Anticholinergic ADRs (oxybutynin may decrease MMSE score in people with dementia)